NDC 61874-130

Vraylar

Cariprazine

Vraylar is a Oral Capsule, Gelatin Coated in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Cariprazine.

Product ID61874-130_03e4d2c4-600f-42a3-966e-254b83f38ccd
NDC61874-130
Product TypeHuman Prescription Drug
Proprietary NameVraylar
Generic NameCariprazine
Dosage FormCapsule, Gelatin Coated
Route of AdministrationORAL
Marketing Start Date2015-09-17
Marketing CategoryNDA / NDA
Application NumberNDA204370
Labeler NameAllergan, Inc.
Substance NameCARIPRAZINE
Active Ingredient Strength3 mg/1
Pharm ClassesAtypical Antipsychotic [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 61874-130-07

7 CAPSULE, GELATIN COATED in 1 BLISTER PACK (61874-130-07)
Marketing Start Date2016-03-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 61874-130-63 [61874013063]

Vraylar CAPSULE, GELATIN COATED
Marketing CategoryNDA
Application NumberNDA204370
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-09-17
Marketing End Date2016-11-28

NDC 61874-130-11 [61874013011]

Vraylar CAPSULE, GELATIN COATED
Marketing CategoryNDA
Application NumberNDA204370
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-09-17

NDC 61874-130-31 [61874013031]

Vraylar CAPSULE, GELATIN COATED
Marketing CategoryNDA
Application NumberNDA204370
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-03-01

NDC 61874-130-20 [61874013020]

Vraylar CAPSULE, GELATIN COATED
Marketing CategoryNDA
Application NumberNDA204370
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-03-01

NDC 61874-130-07 [61874013007]

Vraylar CAPSULE, GELATIN COATED
Marketing CategoryNDA
Application NumberNDA204370
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-03-01

NDC 61874-130-30 [61874013030]

Vraylar CAPSULE, GELATIN COATED
Marketing CategoryNDA
Application NumberNDA204370
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-03-01

NDC 61874-130-90 [61874013090]

Vraylar CAPSULE, GELATIN COATED
Marketing CategoryNDA
Application NumberNDA204370
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-03-01
Marketing End Date2019-05-24

Drug Details

Active Ingredients

IngredientStrength
CARIPRAZINE3 mg/1

OpenFDA Data

SPL SET ID:4b5f7c65-aa2d-452a-b3db-bc85c06ff12f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1667674
  • 1667666
  • 1667676
  • 1667670
  • 1667672
  • 1667660
  • 1667678
  • 1667668
  • 1741747
  • 1741746
  • UPC Code
  • 0361874160307
  • 0304561140077
  • 0361874115307
  • 0361874145304
  • Pharmacological Class

    • Atypical Antipsychotic [EPC]

    Medicade Reported Pricing

    61874013030 VRAYLAR 3 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    61874013020 VRAYLAR 3 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    61874013011 VRAYLAR 3 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Vraylar" or generic name "Cariprazine"

    NDCBrand NameGeneric Name
    61874-115Vraylarcariprazine
    61874-130Vraylarcariprazine
    61874-145Vraylarcariprazine
    61874-160Vraylarcariprazine
    61874-170Vraylarcariprazine
    70518-3157Vraylarcariprazine

    Trademark Results [Vraylar]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    VRAYLAR
    VRAYLAR
    86207461 4973625 Live/Registered
    FOREST LABORATORIES HOLDINGS LTD.
    2014-02-28
    VRAYLAR
    VRAYLAR
    86071684 4956269 Live/Registered
    Forest Laboratories, Inc.
    2013-09-23
    VRAYLAR
    VRAYLAR
    85267930 not registered Dead/Abandoned
    Forest Laboratories, Inc.
    2011-03-15

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.